WA
GILD icon

Westfuller Advisors’s Gilead Sciences GILD Stock Holding History

Westfuller Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$134K Sell
963
-477
-33% -$66.8K 0.06% 173
2025
Q4 		$177K Sell
1,440
-63
-4% -$7.66K 0.07% 157
2025
Q3 		$167K Buy
+1,503
New +$171K 0.08% 164

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Westfuller Advisors's GILD Position: Q1 2026 in Review

Westfuller Advisors reduced its Gilead Sciences (GILD) stake by 33% in Q1 2026, selling an estimated $66.8K and leaving 963 shares worth $134K. The position accounts for 0.06% of the portfolio, ranked #173.

Westfuller Advisors first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. The position peaked at $177K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Westfuller Advisors held 963 shares of Gilead Sciences worth $134K as of Q1 2026.
  • Westfuller Advisors sold 477 Gilead Sciences shares in Q1 2026, an estimated $66.8K.
  • Gilead Sciences made up 0.06% of Westfuller Advisors's portfolio in Q1 2026, its #173 holding.
  • Westfuller Advisors first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • Westfuller Advisors's Gilead Sciences position peaked at $177K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Westfuller Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.